INTRODUCTION
Rifamycin SV is a naphthohydroquinone with antibiotic activity isolated from the micro-organism Nocardia mediterranel which has been especially useful for the treatment of tuberculosis (Sensi et al., 1960; Timbol, 1960; Lester, 1972) . This drug has been reported to have anti-viral, anti-inflammatory and immunosuppressive properties (Subak-Sharpe et al., 1969 ; Kasik and Monick, 1981; Arora and Main, 1984; Caruso et al., 1993) . Both the hydroquinone moiety and the long aliphatic bridge of rifamycin SV are responsible for its pharmacochemical behaviour. Rifamycin SV can undergo autoxidation when exposed to air for a long period of time (Scrutton, 1977; Kono, 1982) . This aerobic oxidation is accelerated by certain metals (Kono, 1982) . Reactive oxygen species (ROS) including 02-i H202 and hydroxyl radical ('OH) are produced in the presence of rifamycin SV, oxygen and metals (Kono, 1982; Kono and Sugiura, 1982; Gutteridge, 1987, 1991; Saez et al., 1991) . Oxidative destruction of DNA by rifamycin SV and copper has been related to the metal-dependent production of ROS Gutteridge, 1987, 1991) . The bactericidal activity ofthis antibiotic has been suggested to be due to its ability to generate ROS (Kono, 1982 ; Kono and Sugiura, 1982; Gutteridge, 1987, 1991; Saez et al., 1991) .
In a previous study designed to characterize the interaction of rifamycin SV with rat liver microsomes (Kukielka and Cederbaum, 1992) , the antibiotic was shown to increase microsomal production of 02--3-fold with NADPH as cofactor, and more than 5-fold with NADH; rates of H202 production were elevated 2-fold with NADPH and 8-fold with NADH. Oxidation of 2-oxo-4-thiomethylbutyrate, taken as a reflection of the production of 'OH-like species, was also elevated by rifamycin SV, especially with NADH as the microsomal reductant (Kukielka and Cederbaum, 1992) . These results indicate that rifamycin SV stimulates microsomal production of ROS, and that, in contrast with results with most redox cycling agents, e.g. paraquat or menadione, is quite effective with NADH as the cofactor.
The current study was carried out to evaluate the stimulation of microsomal 'OH production by rifamycin SV in a more sensitive system than previously employed. Iron is required to catalyse microsomal 'OH production, and, in contrast with NADPH, NADH is much less reactive in catalysing 'OH production with most iron complexes, except for ferric-EDTA (Kukielka and Cederbaum, 1989; Kukielka et al., 1989 ; Kukielka and Cederbaum, 1992) . Indeed, in a previous study (Kukielka and Cederbaum, 1992) , rates of microsomal production of 'OH assessed by oxidation of 2-oxo-4-thiomethylbutyric acid were low and difficult to quantify with most ferric complexes and most studies were carried out with ferric-EDTA. A recent study (Kukielka and Cederbaum, 1994) indicated that DNA strand scission catalysed by rat liver microsomes was a very sensitive assay for the detection of 'OH production as catalysed by a variety of ferric complexes.
The interaction of ROS with DNA has been studied in a variety of systems (Braun and Fridovich, 1981; Muindi et al., Abbreviations used: ROS, reactive oxygen species; DTPA, diethylenetriaminepenta-acetic acid; SOD, superoxide dismutase. 362 E. Kukielka and A. 1. Cederbaum 1985; Myers et al., 1987; Berlin and Heseltine, 1988; Schneider et al., 1988; Sinha et al., 1988; Aruoma et al., 1989; Rumyantseva et al., 1989) . DNA scission is believed to be due to production of OH in these reaction systems. Supercoiled DNA is more compact than circular DNA and can be converted by single-strand breaks into the relaxed open circular state or by double-strand breaks into the linear form (Berlin & Haseltine, 1988; Rumyantseva et al., 1989; Schneider et al., 1988 Schneider et al., , 1989 . These forms can be separated from each other and detected by following their migration in agarose under the influence of an electric field. Using this sensitive assay system, the ability of rifamycin SV to interact with ferric complexes to catalyse microsomal production of OH was evaluated.
MATERIALS AND METHODS
The source of supercoiled DNA was plasmid pBluescript II KS(-). Escherichia coli, strain XLI Blue, was transformed with plasmid pBluescript II KS(-) using caesium chloride (Maniatis et al., 1982) as previously described (Kukielka and Cederbaum, 1994) . DNA concentration was determined from the absorbance at 260 nm.
Liver microsomes were prepared from male Sprague-Dawley rats by minor modifications of the low speed Ca2l-aggregation procedure of Montgomery et al. (1974) . Livers were perfused with 0.9 % NaCl to remove blood, and homogenates were prepared in buffer containing 0.25 M sucrose, 0.05 M Tris/HCl, pH 7.4,0.005 M MgCl2, 0.05 mM desferrioxamine, 0.025 M KCI and 0.008 M CaCl2. The Ca2l-aggregation method was used-to remove ferritin from the microsomes (Montgomery et al., 1974) , and desferrioxamine was added to chelate non-haem iron in the buffers, water or micromes. The microsomes were washed twice with 0.15 M KCl, centrifuged at 100000 g for 60 min, resuspended in 0.15 M KCl and stored at -70 'C. The buffers and water used to prepare all solutions were passed through columns containing Chelex-100 resin to remove metal contamination. Protein was determined by the method of Lowry et al. (1951) .
Rat liver microsomes (typically used at a protein concentration of 8 ,ug) were incubated at 37 'C with 0.5 ,ug of pBluescript II KS(-) in a reaction mixture consisting of 100 mM potassium phosphate buffer, pH 7.4, 50,M ferric chelate, 1.5 mM NADH, and in the presence or absence of 0.4 mM rifamycin SV in a total volume of 50,u. Figure 1 ). No such conversion occurred with microsomes plus ferric-ATP in the absence of NADH, or NADH plus ferric-ATP in the absence of microsomes; some conversion occurred with microsomes plus NADH in the absence of ferric-ATP, probably reflecting the presence of small amounts of iron in the microsomes. The ratio between the two forms was 0.16 for lane 1 and 0.34 for lane 2. The addition of 0.05-0.4 mM rifamycin SV produced an increase in DNA strand cleavage, with form 1I/form I ratios of 0.58, 0.93 and 0.95 obtained from lanes 3-5 respectively. There was no effect of rifamycin SV in the absence of microsomes, or of NADH or the ferric-ATP catalyst. The ability of rifamycin SV to stimulate DNA strand cleavage can be observed as loss of form I or gain of form II in arbitrary units, or percentage conversion of the two forms or the ratio between the two forms. Subsequent results will be reported as the ratio of form 1I/form I, higher ratios being indicative of increased generation of ROS.
A time-course experiment for conversion of form-I DNA into form II by microsomes in the presence of either NADH or NADPH as the reductant is shown in Figure 2 . Ferric-ATP was present as the iron catalyst. In the absence of ferric-ATP, DNA strand cleavage was low, and this low activity was stimulated by 0.4 mM rifamycin SV by only 300%. In the presence of ferric-ATP, there was an increase in the form II/form I ratio as a Table 1 Concentraton-dependent stimulaton of DNA strand cleavage by riamycin SV DNA strand cleavage by rat liver microsomes was assayed as described in the Materials and methods section in the presence of NADH and the indicated concentrations of rifamycin SV. Experiments were carried out for 15 min in the absence of added iron, in the presence of 5 uM ferric-ATP or 5 aM ferric-EDTA. Results are expressed as the ratio of form 11/form and are means + S.E.M. Figure 2b ). The addition of the rifamycin SV resulted in a large increase in NADH-dependent DNA strand cleavage, whereas no effect of rifamycin SV was found with the NADPH-dependent system (Figure 2 ). The concentration-dependence of rifamycin stimulation of NADH-dependent DNA strand cleavage in the absence of added iron or with either ferric-EDTA or ferric-ATP as the iron catalyst is shown in Table 1 . In the absence of added iron, rifamycin, even at concentrations as high as 1 mM, did not significantly increase NADH-dependent DNA strand cleavage. However, in the presence of either ferric-ATP or ferric-EDTA, rifamycin produced a concentration-dependent stimulation of DNA strand cleavage, with significant increases being found at 0.01 to 0.05 mM rifamycin, and maximal increases occurring at 0.4mM rifamycin. Ferric-EDTA, as expected, was a more powerful catalyst of microsomal DNA strand cleavage then was ferric-ATP, in both the absence and presence of rifamycin.
Effect of ferric complexes on DNA strand cleavage
The concentration-dependence of the ability of ferric-ATP to catalyse NADH-dependent DNA strand cleavage in the absence Table 2 Concentration-dependent ferric-ATP stimulation of DNA strand cleavage in the absence and presence of rifamycin SV DNA strand cleavage by microsomes was assayed in the absence or presence of 0.4 mM rifamycin SV and the indicated concentrations of ferric-ATP. Reactions were carried out for 15 min using 6,ug of microsomal protein and NADH as reductant. Results are expressed as the ratio of form 11/form and are means + S.E.M. from three experiments. *P < 0.05, ** P < 0.01, *** P < 0.001, compared with the value in the absence of rifamycin SV. concentration of ferric-ATP was elevated. A variety of other ferric complexes besides ferric-ATP were also studied (Table 3) . DNA strand cleavage in the absence of added iron was partially inhibited by desferrioxamine suggesting a role for iron in the system or microsomes participating in the reaction. Ferriccitrate, ferric-histidine, ferric-ATP, and ferric-(NH4)2SO4 were all effective at promoting NADH-dependent microsomal DNA strand cleavage. The most effective catalysts were ferric-EDTA and ferric-diethylenetriaminepenta-acetic acid (DTPA). Rifamycin slightly stimulated the formIl/form I ratio in the absence of added iron; this stimulation was completely blocked in the presence of desferrioxamine, indicating that it was dependent on iron present in the reaction system. Rifamycin stimulated DNA strand cleavage with ferric-ATP (2.5-fold), ferric-citrate (3.7-fold), ferric-(NH4)2SO4 (4-fold), ferric-histidine (6.4-fold) and ferric-EDTA (8-fold). However, stimulation by rifamycin with ferric-DTPA was poor (1.6-fold), although this ferric complex in the absence of rifamycin is as powerful a catalyst for DNA strand cleavage as is ferric-EDTA.
Effect of anti-oxidants on rifamycin stimulation
The effect of catalase and superoxide dismutase (SOD) on DNA strand cleavage was studied to evaluate the role of H202 and 02--in the reaction pathway. Four different ferric catalysts were used in the presence of 0.4 mM rifamycin. The concentration of the iron was high, 50 ,uM, and the reaction period was prolonged to 30 min in order to cause nearly complete conversion of form-I DNA into form II, thereby allowing clear evaluation of the various anti-oxidants tested. Catalase produced complete inhibition of the extensive DNA strand cleavage catalysed by the four ferric complexes in the presence of rifamycin (Table 4) ; catalase was previously shown to inhibit the conversion of form I into form II in the absence of rifamycin as well (Kukielka and Cederbaum, 1994) . SOD was also a powerful inhibitor of DNA strand cleavage catalysed by rifamycin in the presence of ferrichistidine, ferric-ATP and ferric-(NH4)2SO4, but was not significantly inhibitory against the ferric-EDTA system. To evaluate a role for 'OH in DNA strand cleavage stimulated by rifamycin, the effect ofa variety ofcompetitive OH scavengers was determined (Table 5) . With all four ferric complexes, dimethyl sulphoxide, ethanol and the spin-trapping agent, 5,5-dimethylpyroline-N-oxide, produced strong inhibition of rifamycin-stimulated DNA strand cleavage. GSH was also a very effective inhibitor. Several other OH scavengers found to be more than 85 % protective, include mannitol (50 mM) and glycerol (100 mM). In contrast, propyl gallate and butylated hydroxytoluene, used at concentrations that completely prevent lipid peroxidation determined as the production of thiobarbituric acid-reactive components, did not or only partially prevented the rifamycin stimulation of microsomal DNA strand cleavage.
Comparison with menadione and paraquat
Menadione and paraquat are widely used redox cycling agents which produce large increases in microsomal production of ROS (Lind and Ernster, 1974; Bus et al., 1976; Bachur et al., 1979; Trush et al., 1981 Trush et al., , 1982 Thor et al., 1982; Cadenas et al., 1983; Powis, 1987) . These agents are considerably more reactive with NADPH than with NADH as the microsomal reductant (Iyanagi and Yamazaki, 1969; Lind and Ernster, 1974; Bus et al., 1976; Hassan and Fridovich, 1979; Kappus, 1986; Liochev and Fridovich, 1988) . Figure 3(a) , lanes 2-5, shows that, in the presence of NADH and desferrioxamine, which was added to chelate iron in the microsomes or reaction system, rifamycin, paraquat and menadione had little or a small stimulatory effect on DNA strand cleavage. The three agents produced an increase in form I into form II conversion in the presence of ferric-ATP, especially at the 50,M iron concentration (Figure 3a , lanes 9-13). Quantification of the gel is shown in Table 6 ; under these reaction conditions and at the concentrations utilized, menadione was the most effective stimulator of NADH-dependent DNA strand cleavage, and paraquat was the least effective. When NADPH was used as the microsomal reductant, there was some conversion of form-I DNA into form II by rifamycin, paraquat and menadione in the presence of2 ,tM desferrioxamine ( Figure 3b, lanes 2-5) . Extensive conversion of form I into form II was found with NADPH in the presence of 50 /tM ferric-ATP (lane 6); both paraquat and menadione potentiated this conversion by causing formation of linear DNA (form III; lanes 8 and 9). Rifamycin was not effective in producing linear DNA (lane 7).
DISCUSSION
ROS are produced when the antibiotic rifamycin SV is incubated with metals and oxygen (Kono, 1982; Kono and Sugiura, 1982; Gutteridge, 1987, 1991; Saez et al., 1991) , and the anti-bacterial activity of this agent may involve, in part, production of ROS. Rifamycin SV was previously shown to stimulate microsomal production of 02-and H202, especially with NADH as the microsomal reductant (Kukielka and Cederbaum, 1992) . Since 02--and H202 can, in the presence of metal catalysts, generate 'OH via Fenton-or Haber-Weiss-types of reaction, the ability of rifamycin SV to stimulate microsomal production of 'OH was determined. Conversion of supercoiled DNA into the open circular form has been demonstrated in a variety of systems that generate ROS, mainly 'OH-like species (Braun and Fridovich, 1981; Muindi et al., 1985; Myers et al., 1987; Berlin and Haseltine, 1988; Schneider et al., 1988 Schneider et al., , 1989 Sinha et al., 1988; Aruoma et al., 1989; Rumyantseva et al., 1989) , and this system appears to be very sensitive for the detection of OH produced by rat liver microsomes (Kukielka and Cederbaum, 1994 (Morehouse and Aust, 1988; Puntarulo and Cederbaum, 1988) . One difference between ferric-EDTA and three other ferric complexes in catalysing the rifamycin stimulation of DNA strand cleavage is that SOD fails to inhibit the ferric-EDTA-catalysed reaction, whereas it completely inhibits the rifamycin stimulation found with ferric-ATP, ferric-histidine and ferric-(NH4)2SO4. Ferric-EDTA can be directly reduced by microsomal reductases such as NADPHcytochrome P-450 reductase and NADH-cytochrome b6 reductase (Morehouse and Aust, 1988; Morehouse et al., 1984) , hence the inability of SOD to inhibit is probably due to the lack of a requirement for 02-. to reduce ferric-EDTA. Reduction of ferric-ATP and other ferric complexes by these reductases is inefficient (Jansson and Schenkman, 1977; Hirokata et al., 1978; Morehouse et al., 1984; Morehouse and Aust, 1988; Vegh et al., 1988 ) the strong inhibition of DNA strand cleavage by SOD indicates that 02-' largely generated from cytochrome P-450 and not the reductases, plays an important role in the reduction of these ferric complexes, hence SOD is a powerful inhibitor of OH production. It would appear that the stimulation of NADHdependent production of 02--by rifamycin SV (Kukielka and Cederbaum, 1992 ) plays a dual role in the overall ability of rifamycin SV to stimulate DNA strand cleavage: one role is to reduce ferric complexes such as ferric-ATP, ferric-histidine and ferric-(NH4)2SO4 and the second is to provide the H202 which serves as the precursor of the ultimate oxidant, OH. The poor stimulation by rifamycin SV of NADPH-dependent DNA strand cleavage probably reflects the elevated activity found with this cofactor compared with NADH, which, in turn, is probably due to the higher rates ofproduction of02-and H202 by microsomes with NADPH than with NADH. The greater effectiveness with NADH may also be due to interaction of rifamycin SV (in contrast with paraquat) with NADH-cytochrome b5 reductase or cytochrome b5.
The fact that ferric-DTPA is not effectively reduced by 02-- (Buettner et al., 1978; Cohen and Sinet, 1982) probably explains why the stimulation of DNA strand cleavage by rifamycin is poor with this iron complex relative to the others. Rifamycin stimulation of H202 production (via O2-dismutation) probably accounts for the striking DNA strand cleavage that occurs in the presence of ferric-EDTA.
Rates of OH production and DNA strand cleavage by microsomes are higher with NADPH than with NADH as the augmenting the high NADPH-dependent rates, although paraquat and menadione are, generating linear DNA from supercoiled DNA. Paraquat is much less effective than menadione in promoting NADH-dependent microsomal production of ROS (lyanagi and Yamazaki, 1969; Hassan and Fridovich, 1979; Kappus, 1986-Liochev and Fridovich, 1988) and in catalysing DNA strand cleavage. Rifamycin, in contrast with menadione and paraquat, is more effective at catalysing NADH-dependent microsomal DNA strand cleavage than at catalysing the NADPH-dependent reaction. However, menadione appears to be the most reactive of the three redox cycling agents with both microsomal reductants.
In summary, these results indicate that rifamycin SV can increase microsomal production of ROS which are capable of causing DNA strand cleavage. Rifamycin stimulation requires an iron catalyst and is probably the result of the increased production of 02-. and H202 as a consequence of rifamycin interaction with the microsomes. In contrast with other typical redox cycling agents, the stimulation by rifamycin is much more prominent with NADH than with NADPH as the microsomal reductant. Pallanza et al. (1967) and Furesz et al. (1967) have shown that an oral derivative of rifamycin is concentrated in the liver and slowly eliminated. Hepatic concentrations after administration of oral doses ranging from 2 to 10 mg/kg body weight of rifampicin to mice, guinea pigs and human volunteers ranged from 22 to 67 ,g/g of liver or approx. 0.03-0.10 mM. As shown in Table 1 , these concentrations of rifamycin SV produced two-or three-fold increases in NADH-dependent microsomal production of 0OH. It is possible that interaction of rifamycin, NADH and iron to generate 2--may play a role in some of the hepatotoxic side effects associated with the use of the antibacterial antibiotic when used alone or in combination with other drugs in the treatment of tuberculosis (LeSobre et al., 1969; Hollins and Simmons, 1970; Lees et al., 1971a,b) . These interactions may also play a role in the cytocidal activity of rifamycin SV.
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